Shenouda Maged

Executive buyer

Chief Financial Officer · RELMADA THERAPEUTICS, INC.

Every open-market stock purchase Shenouda Maged has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.

Total bought

$1.9M

Open-market buys

Companies

Last buy

Sep 10, 2026

Where the buys stand today

RLMD
RELMADA THERAPEUTICS, INC.
3 purchases totalling $1.9M at an average of $2.78 per share. See all insider buying in RLMD →
Avg price paid
$2.78
Latest price
—
Market cap
Unknown

Cluster participation

Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.

All reported buys

Date	Ticker	Shares	Price	Value	Filing
Sep 10, 2026	RLMDcluster	79,800	$4.25	$339.2K	SEC ↗
Sep 9, 2026	RLMDcluster	120,200	$4.20	$504.8K	SEC ↗
Nov 5, 2025	RLMDcluster	500,000	$2.20	$1.1M	SEC ↗

Follow new qualifying clusters involving Shenouda Maged or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

Start a trial See pricing

About this data

Figures are parsed from Shenouda Maged's Form 4 filings on SEC EDGAR (CIK 1658369) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.